OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Peripheral Glycolysis in Neurodegenerative Diseases
Simon Bell, Toby Burgess, James Lee, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 23, pp. 8924-8924
Open Access | Times Cited: 58

Showing 1-25 of 58 citing articles:

Mitochondria: It is all about energy
Amaloha Casanova, Anne Wevers, Santiago Navarro‐Ledesma, et al.
Frontiers in Physiology (2023) Vol. 14
Open Access | Times Cited: 95

Mitochondrial dysfunctions, oxidative stress and neuroinflammation as therapeutic targets for neurodegenerative diseases: An update on current advances and impediments
Muneeb U. Rehman, Nouroz Sehar, Nawab John Dar, et al.
Neuroscience & Biobehavioral Reviews (2022) Vol. 144, pp. 104961-104961
Closed Access | Times Cited: 75

Unravelling cell type-specific responses to Parkinson’s Disease at single cell resolution
Araks Martirosyan, Rizwan Ansari, Francisco Pestana, et al.
Molecular Neurodegeneration (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 31

Mitochondrial Dysfunction in Alzheimer’s Disease: A Biomarker of the Future?
Simon Bell, Katy Barnes, Matteo De Marco, et al.
Biomedicines (2021) Vol. 9, Iss. 1, pp. 63-63
Open Access | Times Cited: 95

Synapses: The Brain’s Energy-Demanding Sites
Andreia Faria‐Pereira, Vanessa A. Morais
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3627-3627
Open Access | Times Cited: 68

Astrocyte-Neuron Metabolic Crosstalk in Neurodegeneration: A Mitochondrial Perspective
Patrycja Mulica, Anne Grünewald, Sandro L. Pereira
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 64

Mitochondrial Sirtuins in Parkinson’s Disease
Ling He, Jihong Wang, Yazhi Yang, et al.
Neurochemical Research (2022) Vol. 47, Iss. 6, pp. 1491-1502
Closed Access | Times Cited: 40

The regulatory roles and clinical significance of glycolysis in tumor
Qiqi Qiao, Shunfeng Hu, Xin Wang
Cancer Communications (2024) Vol. 44, Iss. 7, pp. 761-786
Open Access | Times Cited: 10

Role of SNAREs in Neurodegenerative Diseases
Azzurra Margiotta
Cells (2021) Vol. 10, Iss. 5, pp. 991-991
Open Access | Times Cited: 55

NADPH and Mitochondrial Quality Control as Targets for a Circadian-Based Fasting and Exercise Therapy for the Treatment of Parkinson’s Disease
William M. Curtis, William A. Seeds, Mark P. Mattson, et al.
Cells (2022) Vol. 11, Iss. 15, pp. 2416-2416
Open Access | Times Cited: 36

The role of NURR1 in metabolic abnormalities of Parkinson’s disease
Murad Al‐Nusaif, Yuting Yang, Song Li, et al.
Molecular Neurodegeneration (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 31

Fecal microbiota transplantation significantly improved respiratory failure of amyotrophic lateral sclerosis
Jingshuang Yan, Huixin Chen, Yan Zhang, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 6

Monitoring and modelling the dynamics of the cellular glycolysis pathway: A review and future perspectives
Nitin Patil, Orla Howe, Paul A. Cahill, et al.
Molecular Metabolism (2022) Vol. 66, pp. 101635-101635
Open Access | Times Cited: 24

Exploring glycolytic enzymes in disease: potential biomarkers and therapeutic targets in neurodegeneration, cancer and parasitic infections
Maura Rojas-Pirela, Diego Andrade-Alviárez, Verónica Rojas, et al.
Open Biology (2025) Vol. 15, Iss. 2
Open Access

Human glycolysis isomerases are inhibited by weak metabolite modulators
Yiming Yang Jónatansdóttir, Óttar Rolfsson, Jens G. Hjörleifsson
FEBS Journal (2025)
Closed Access

Therapeutic Opportunities for Food Supplements in Neurodegenerative Disease and Depression
Rita Businaro, David Vauzour, Jerome Sarris, et al.
Frontiers in Nutrition (2021) Vol. 8
Open Access | Times Cited: 29

Melatonin: Regulation of Biomolecular Condensates in Neurodegenerative Disorders
Doris Loh, Rüssel J. Reiter
Antioxidants (2021) Vol. 10, Iss. 9, pp. 1483-1483
Open Access | Times Cited: 28

Cdk5 and aberrant cell cycle activation at the core of neurodegeneration
Raquel Requejo-Aguilar
Neural Regeneration Research (2022) Vol. 18, Iss. 6, pp. 1186-1186
Open Access | Times Cited: 21

Dopamine modification of glycolytic enzymes impairs glycolysis: possible implications for Parkinson’s disease
Bing Chen, Qian Zhang, Xiaoru Zhong, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4

Poly(ADP‐ribose) mediates bioenergetic defects and redox imbalance in neurons following oxygen and glucose deprivation
M. Iqbal Hossain, Jun Hee Lee, Jean‐Philippe Gagné, et al.
The FASEB Journal (2024) Vol. 38, Iss. 6
Open Access | Times Cited: 4

Blood-Based Biomarkers in Alzheimer’s Disease: Advancing Non-Invasive Diagnostics and Prognostics
Mrinmay Dhauria, Ritwick Mondal, Shramana Deb, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 10911-10911
Open Access | Times Cited: 4

Therapeutic Efficacy of Small Extracellular Vesicles Loaded with ROCK Inhibitor in Parkinson’s Disease
Candy Carbajal, Myosotys Rodriguez, Florida Owens, et al.
Pharmaceutics (2025) Vol. 17, Iss. 3, pp. 365-365
Open Access

Page 1 - Next Page

Scroll to top